[1] 时颖华,李中东,王大猷.别嘌醇致混合型药疹[J].药物不良反应杂志,2000,2(1):50. [2] Beurgdorf W H C,Plewig G,Wolff H H,et al.Severe cutaneous adversereactions.Braun-Falco's Dermatology[M].3版,Heidelberg,2008: 473-483. [3] Yip L W,Thong B Y,Lim J,et al.Ocular manifestations and complicationsof Stevens-Johnson syndrome and toxic epidermal necrolysis: anAsian series[J].Allergy,2007,62(5):527-531. [4] Lebargy F,Wolkenstein P,Gisselbrecht M,et al.Pulmonary complicationsin toxic epidermal necrolysis: a prospective clinical study[J].Intensive Care Med,1997,23(12): 1237-1244. [5] Revuz J,Penso D,Roujeau J C,et al.Toxic epidermal necrolysis.Clinical findings and prognosis factors in 87 patients.Arch Derm-atol[J].1987,123(9):1160-1165. [6] Bastuji-Garin S,Rzany B,Stern R S,et al.Clinical classification ofcases of toxic epidermal necrolysis,Stevens-Johnson syndrome,anderythemamultiforme[J].Arch Dermatol,1993,129(1): 92-96. [7] Magina S,Lisboa C,Leal V,et al.Dermatological and ophthalmologicalsequels in toxic epidermal necrolysis[J].Dermatology,2003,207(1):33-36. [8] Sheridan R L,Schulz J T,Ryan C M,et al.Long-term consequences oftoxic epidermal necrolysis in children[J].Pediatrics,2002,109(1):74-78. |